Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

Share

Xellia Pharmaceuticals AS

Closing information (x1000 DKK)

Closing information 2024/12 2023/12 2022/12
Turnover 52,360 More Arrow 56,936 More Arrow 62,868
Financial expenses 2 More Arrow 9 Less Arrow 2
Earnings before taxes 54,307 Less Arrow 33,555 More Arrow 36,804
Total assets 492,033 Less Arrow 485,496 Less Arrow 480,975
Current assets 164,973 Less Arrow 161,781 Less Arrow 150,501
Current liabilities 44,854 Less Arrow 36,088 Less Arrow 13,209
Equity capital 445,361 More Arrow 447,173 More Arrow 465,224
- share capital 140,596 More Arrow 148,027 More Arrow 157,718

Financial ratios

Fiscal year 2024/12 2023/12 2022/12
Solvency 90.5% More Arrow 92.1% More Arrow 96.7%
Turnover per employee
Profit as a percentage of turnover 103.7% Less Arrow 58.9% Less Arrow 58.5%
Return on assets (ROA) 11.0% Less Arrow 6.9% More Arrow 7.7%
Current ratio 367.8% More Arrow 448.3% More Arrow 1139.4%
Return on equity (ROE) 12.2% Less Arrow 7.5% More Arrow 7.9%
Change turnover -1,717 Less Arrow -2,069 More Arrow 11,119
Change turnover % -3% Less Arrow -4% More Arrow 21%
Chg. No. of employees
Chg. No. of employees %

Total value of public sale

Fiscal year 2024/12 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.